Antihistamine drug proven effective in treating Alzheimer's
A drug previously approved as an antihistamine in Russia may serve as a potential treatment for Alzheimer's disease, new findings indicate.
The study from the Baylor College of Medicine (BCM) in Houston found that Dimebon improved thinking processes and the overall ability to function when administered to patients with Alzheimer's.
Lead researcher Dr Rachelle Doody, professor of neurology at BCM, said: "More research is needed, but we are encouraged by the effect the drug Dimebon had on Alzheimer's patients. What we saw in the clinical trial is that people on the medication continued to improve over time."
Over the space of a year, the drug led to continued improvement in patients with Alzheimer's, while those on the placebo declined.
The authors of the report believe the medication works by stabilizing mitochondria and inhibiting brain cell death.
Dr Doody added: "As we continue research, we hope to replicate these results. My belief is that this drug will turn out to be useful for Alzheimer's disease, regardless of the stage of the disease."
Health Headlines MORE »
For every 10 g per day increase in soluble fiber intake, a woman may reduce her risk of breast cancer by up to 26%.
Peptides from soybeans modulate neurotransmitters, thereby helping to boost circulation in the brain.
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
